SEARCH RESULTS FOR:

Mark A. Goldberg

CEO, ALLUCENT
"Given that a significant amount of intellectual property and cutting-edge science resides within smaller companies, we created a purpose-built firm to help smaller players develop their products and bring them to market."

Rajendra Shah & Janki Shah

DIRECTOR (RS) AND DIRECTOR (JS), MERCURY LABORATORIES
"After the pandemic, India has become one of the most recognized medical suppliers to the world as the country has shown that it can supply to ever increasing demands."

Akbar Thayoob

PRESIDENT, MALAYSIAN PETROCHEMICALS ASSOCIATION (MPA)
"The dynamics of competition are highly fluid today, and I believe the industry will find success in well-defined, specifically targeted products rather than by competing with the same undifferentiated products."

Gil Roth

PRESIDENT, PBOA
"The Ukraine crisis highlighted how Europe needs to look at its energy supply and how it will make sure they have secure supply chains. Part of that has involved the US more closely. Geopolitics will have a more significant impact going forward."

Terry Myerson

CEO, TRUVETA
"Truveta Studio is the first data and analytics solution to study patient care and outcomes for all conditions, drugs, and medical devices. Pfizer is using Truveta Studio to study COVID-19."

Juice Lambert

PRESIDENT, TITAN ENVIRONMENTAL CONTAINMENT
"We must work toward both human safety and environmental safety, and because our products typically prevent issues such as seepage and contamination of the soil and groundwater, mistakes can be very dangerous."

Nigel Fung & Neal Reynolds

PARTNER AMERICAS (NF) & PARTNER (NR), CSA GLOBAL
"Advanced data analysis is a huge growth area, and we are overloaded with opportunities for our team to address issues to optimize operations at the study and operational stages."

James Longshore

CO-FOUNDER AND CEO, XTRA-GOLD RESOURCES
"I strongly believe Kibi has room to grow into a multi-million oz deposit and become the next big discovery in Ghana."

Oliver Dallaway

DIRECTOR, AFRICAN MINING SERVICES (AMS)
"The whole point of our work in the country is to empower Congolese people and give them a sense of achievement. AMS only hires locally."

Ajay Tandon

MANAGING DIRECTOR, VEEDA CLINICAL RESEARCH
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

MACIG 2025 - Mining in Africa Country Investment Guide

It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.

PARTNER EVENTS